2
Clinical Trials associated with Insulin Glargine/Insulin Lispro(Tonghua Dongbao Pharmaceutical Co., Ltd.) / CompletedNot ApplicableIIT Efficacy and Safety of Insulin Glargine 300 U/mL versus Insulin Degludec in Patients with Type 2 Diabetes: A Randomized, Open-Label, Crossover Study Using Continuous Glucose Monitoring Profiles - Efficacy and Safety of Insulin Glargine 300 U/mL versus Insulin Degludec in Patients with Type 2 Diabetes: A Randomized, Open-Label, Crossover Study Using Continuous Glucose Monitoring Profiles
Start Date01 Jun 2016 |
Sponsor / Collaborator- |
/ CompletedNot ApplicableIIT Insulin glargine 300 U/ml versus insulin degludec 100 U/ml in type 2 diabetic patients treated with basal-bolus insulin therapy - Insulin glargine 300 U/ml versus insulin degludec 100 U/ml in type 2 diabetic patients treated with basal-bolus insulin therapy
Start Date01 Dec 2015 |
Sponsor / Collaborator- |
100 Clinical Results associated with Insulin Glargine/Insulin Lispro(Tonghua Dongbao Pharmaceutical Co., Ltd.)
100 Translational Medicine associated with Insulin Glargine/Insulin Lispro(Tonghua Dongbao Pharmaceutical Co., Ltd.)
100 Patents (Medical) associated with Insulin Glargine/Insulin Lispro(Tonghua Dongbao Pharmaceutical Co., Ltd.)
100 Deals associated with Insulin Glargine/Insulin Lispro(Tonghua Dongbao Pharmaceutical Co., Ltd.)